Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension

Published:2019-05 Issue:20 Volume:73 Page:2567-2580
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Dai Yong,Chen Xiao,Song Xiaoxiao,Chen Xijun,Ma Wenrui,Lin Jibin,Wu Hailang,Hu Xiajun,Zhou Yanzhao,Zhang Hongrong,Liao Yuhua,Qiu Zhihua,Zhou Zihua

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2. Advances in therapeutic interventions for patients with pulmonary arterial hypertension;Humbert;Circulation,2014

3. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses;Galiè;Eur Heart J,2010

4. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension;Boucly;Eur Respir J,2017

5. New approaches in the treatment of hypertension;Oparil;Cir Res,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safflower Alleviates Pulmonary Arterial Hypertension by Inactivating NLRP3: A Combined Approach of Network Pharmacology and Experimental Verification;The Clinical Respiratory Journal;2024-08

2. Structural basis of antagonist selectivity in endothelin receptors;Cell Discovery;2024-07-30

3. Preparation of the new peptide drug ACTY116‐loaded in situ forming implants and evaluation of its efficacy in pulmonary arterial hypertension and right ventricular hypertrophy induced by SU5416/hypoxia in mice;Basic & Clinical Pharmacology & Toxicology;2024-05-20

4. B-cells in pulmonary arterial hypertension: friend, foe or bystander?;European Respiratory Journal;2024-03-14

5. Combined vaccines against angiotensin II receptor type 1 and alpha 1D-adrenergic receptor for hypertension;Journal of Hypertension;2024-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3